SG Americas Securities LLC decreased its holdings in Owens & Minor, Inc. (NYSE:OMI – Free Report) by 66.3% during the 4th quarter, HoldingsChannel reports. The fund owned 10,618 shares of the company’s stock after selling 20,882 shares during the quarter. SG Americas Securities LLC’s holdings in Owens & Minor were worth $139,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in the business. The Manufacturers Life Insurance Company raised its holdings in shares of Owens & Minor by 4.9% during the second quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company’s stock worth $491,000 after purchasing an additional 1,709 shares during the period. Blue Trust Inc. raised its holdings in shares of Owens & Minor by 176.8% during the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after buying an additional 1,780 shares during the last quarter. Segall Bryant & Hamill LLC lifted its holdings in Owens & Minor by 2.1% in the third quarter. Segall Bryant & Hamill LLC now owns 137,199 shares of the company’s stock worth $2,153,000 after purchasing an additional 2,883 shares during the period. Marshall Wace LLP raised its holdings in Owens & Minor by 38.4% during the second quarter. Marshall Wace LLP now owns 11,100 shares of the company’s stock worth $150,000 after purchasing an additional 3,077 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in Owens & Minor by 6.5% during the 3rd quarter. Franklin Resources Inc. now owns 61,223 shares of the company’s stock valued at $961,000 after purchasing an additional 3,743 shares in the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Robert W. Baird reduced their price objective on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, February 4th. UBS Group dropped their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Citigroup reduced their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Finally, Barclays reduced their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Owens & Minor presently has a consensus rating of “Hold” and an average target price of $18.50.
Owens & Minor Stock Performance
Shares of Owens & Minor stock opened at $8.47 on Tuesday. The firm has a market cap of $652.74 million, a P/E ratio of -13.02, a P/E/G ratio of 0.25 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a 50 day simple moving average of $13.30 and a 200 day simple moving average of $14.04. Owens & Minor, Inc. has a fifty-two week low of $8.39 and a fifty-two week high of $28.35.
Insider Buying and Selling at Owens & Minor
In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 3.59% of the company’s stock.
Owens & Minor Profile
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Read More
- Five stocks we like better than Owens & Minor
- Quiet Period Expirations Explained
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Fintech Stocks With Good 2021 Prospects
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Top Stocks Investing in 5G Technology
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.